Skip to content
EN  |  JP
CMIC | Pharmaceutical Development Services (CRO, CDMO, CSO, Healthcare, Japan Entry) Logo CMIC | Pharmaceutical Development Services (CRO, CDMO, CSO, Healthcare, Japan Entry) Logo CMIC | Pharmaceutical Development Services (CRO, CDMO, CSO, Healthcare, Japan Entry) Logo
  • About CMIC
    • About CMIC
    • History of CMIC
    • Pharmaceutical Value Creator
    • CMIC's Creed
    • Executive Leadership
    • Group Companies
    • Corporate Governance
    • CSR
    • Compliance
    • Company Awards & Recognitions
    • Investor Relations >
      • Overview >
        • Management Policy
        • Message from CEO and COO
        • Financial Highlights
        • CSR
      • IR Schedule
      • Corporate Governance
      • Financial Results
      • Stock Information >
        • Stock and Share
        • Dividends
        • Shareholders Meeting
        • Rating
      • Investors FAQ >
        • Glossary
        • FAQ About Company Profile
        • FAQ About Financial Results
        • FAQ About Stock
      • IR Disclosure/Disclaimer
    • Locations
    • Policies
  • Solutions
    • Services >
      • Clinical Trials
      • Commercial Supply
      • Consulting Services
      • Development & Manufacturing
      • Laboratory
      • Market Approval Consulting
      • Medical Affairs
      • Patient & Healthcare Services
      • Post-marketing Surveillance
      • Regulatory Affairs
      • Sales & Marketing
      • Site & Patient Support
    • Tailored Solutions >
      • Asia Clinical Trials
      • Japan Market Entry & IPM
      • Medical Devices & IVD
      • Oncology Drug
      • Orphan Drug
      • Cell & Gene Therapy
    • Browse All Services
  • News & Events
  • Resources
  • Investor Relations
  • Careers
  • Locations
  • Contact

19th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS)

19th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS)

Home >  News & Events >  19th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS)

19th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS)

About 19th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS)

Event Name 19th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS)
Date October 22, 2023 - October 25, 2023
Location Barcelona, Spain
CMIC's Booth

Visit our US Bioanalytical Experts! Booth #TBA

Schedule a Booth Meeting Here >>

Inquiries about our services

Click below if you are interested in outsourcing your operations to us.

Contact Us
  • About CMIC Group
  • Solutions
  • News & Events
  • Resources
  • Careers
  • Contact
© CMIC HOLDINGS Co., LTD. All rights reserved.
TwitterLinkedIn
  • Information Security Policy
  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • GDPR Compliance

  • For access to this link, please complete this short form.

  • This field is for validation purposes and should be left unchanged.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
  • About CMIC
    • CMIC’s Creed
      • Compliance
      • Corporate Governance
      • CSR
      • Activity Reports
      • Approaches to Diversity
      • Back
    • Pharmaceutical Value Creator
    • History of CMIC
    • Executive Leadership
    • Investor Relations
      • Overview
        • Management Policy
        • Message from CEO and COO
        • Financial Highlights
        • History of CMIC – OLD
        • CSR
        • Back
      • IR Schedule
      • Corporate Governance
      • Stock Information
        • Stock and Share
        • Dividends
        • Shareholders Meeting
        • Rating
        • Back
      • Investors FAQ
        • Glossary
        • FAQ About Company Profile
        • FAQ About Financial Results
        • FAQ About Stock
        • Back
      • IR Disclosure/Disclaimer
      • Back
    • Careers
    • Locations
    • Privacy Policy
    • Back
  • Solutions
    • Services
      • Clinical Trials
      • Commercial Supply
      • Consulting Services
      • Development & Manufacturing
      • Laboratory
      • Market Approval Consulting
      • Medical Affairs
      • Patient & Healthcare Services
      • Post-Marketing Surveillance
      • Regulatory Affairs
      • Sales & Marketing
      • Site & Patient Support
      • Back
    • Tailored Solutions
      • Asia Clinical Trials
      • Japan Market Entry & IPM
      • Medical Devices & IVD
      • Oncology Services
      • Orphan Drug
      • Cell & Gene Therapy / Regenerative Medicine
      • Back
    • All Services
    • Back
  • News & Events
  • Resources
  • Investor Relations
  • Careers
  • Locations
  • Contact
  • About CMIC
    • CMIC’s Creed
      • Compliance
      • Corporate Governance
      • CSR
      • Activity Reports
      • Approaches to Diversity
      • Back
    • Pharmaceutical Value Creator
    • History of CMIC
    • Executive Leadership
    • Investor Relations
      • Overview
        • Management Policy
        • Message from CEO and COO
        • Financial Highlights
        • History of CMIC – OLD
        • CSR
        • Back
      • IR Schedule
      • Corporate Governance
      • Stock Information
        • Stock and Share
        • Dividends
        • Shareholders Meeting
        • Rating
        • Back
      • Investors FAQ
        • Glossary
        • FAQ About Company Profile
        • FAQ About Financial Results
        • FAQ About Stock
        • Back
      • IR Disclosure/Disclaimer
      • Back
    • Careers
    • Locations
    • Privacy Policy
    • Back
  • Solutions
    • Services
      • Clinical Trials
      • Commercial Supply
      • Consulting Services
      • Development & Manufacturing
      • Laboratory
      • Market Approval Consulting
      • Medical Affairs
      • Patient & Healthcare Services
      • Post-Marketing Surveillance
      • Regulatory Affairs
      • Sales & Marketing
      • Site & Patient Support
      • Back
    • Tailored Solutions
      • Asia Clinical Trials
      • Japan Market Entry & IPM
      • Medical Devices & IVD
      • Oncology Services
      • Orphan Drug
      • Cell & Gene Therapy / Regenerative Medicine
      • Back
    • All Services
    • Back
  • News & Events
  • Resources
  • Investor Relations
  • Careers
  • Locations
  • Contact
EN  |  JP